Disclosures for "Patient-reported Impact of ≥75% Increase in Good Days/Month on Migraine Symptoms, Quality of Life, and Brain Fog: Real-world Study of Adults With Chronic Migraine Treated With Eptinezumab"
-
Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nevro. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for XGene. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Colllegium. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. Dr. Argoff has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Scilex. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Scilex. The institution of Dr. Argoff has received research support from Lilly. The institution of Dr. Argoff has received research support from Lundbeck. The institution of Dr. Argoff has received research support from Abbvie. The institution of Dr. Argoff has received research support from Vertex. Dr. Argoff has received publishing royalties from a publication relating to health care.
-
Dr. Herzog has nothing to disclose.
-
Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
-
Seema Soni-Brahmbhatt has nothing to disclose.
-
Susanne Awad has received personal compensation for serving as an employee of Lundbeck.
-
Ms. Grossman has received personal compensation for serving as an employee of Lundbeck. Ms. Grossman has received personal compensation for serving as an employee of Horizon Therapeutics. Ms. Grossman has received research support from AbbVie.
-
Dr. Patel has nothing to disclose.
-
Dr. Khan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Khan has received personal compensation in the range of $0-$499 for serving as a Consultant for LivaNova. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epitel. Dr. Khan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer. Dr. Khan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Khan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Khan has received research support from Marinus. The institution of Dr. Khan has received research support from UCB. The institution of Dr. Khan has received research support from Teva. Dr. Khan has a non-compensated relationship as a Ad board with Louisiana State Medical Advisory Board that is relevant to AAN interests or activities.